Patient Commitment Duration:
The KONFIDENT Study lasts approximately 25 weeks with 6 visits or televisits (phone call or video chat) for health checks and tests at no cost to you.
If you join this study, you will treat 3 HAE attacks, with either 300mg or 600mg of KVD900 or placebo, in a random order. The placebo looks like KVD900 but does not have medicine in it. This helps the researchers to better understand the effects of KVD900.
Electronic Diary (eDiary):
You will use an electronic diary to answer questions about your HAE attacks and to determine if you should treat the attack using the study medication or your regular on-demand medication.